Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label Study of the Safety and Contraceptive Efficacy of BufferGel® Spermicide Used With Diaphragm

NCT00397670 is registered in ClinicalTrials.gov with ReProtect Inc as lead sponsor.

NCT NCT00397670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00397670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label Study of the Safety and Contraceptive Efficacy of BufferGel® Spermicide Used With Diaphragm
Lead sponsor
ReProtect Inc
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2004
Completion date
May 31, 2006
Enrollment
200
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception